CannBioRx Life Sciences C...

0.01
0.00 (16.28%)
At close: Jan 27, 2025, 2:57 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -19.94M -38.73M -20.32M -10.88M -25.39M -14.50M 123.76K
Depreciation & Amortization 105.67K 109.00K 109.95K 125.33K 72.24K 23.08K n/a
Stock-Based Compensation 2.28M 2.97M 5.00M 1.12M 13.30M 4.60M n/a
Other Working Capital -300.51K 1.51M -3.08M 105.35K 140.99K -117.52K 53.56K
Other Non-Cash Items 8.99M 22.08M 6.82M 3.46M 5.68M 6.07M -567.56K
Deferred Income Tax -2.35M -942.75K -24.80K -20.43K -9.50K n/a n/a
Change in Working Capital -14.10K 2.72M -8.81M 2.33M 3.04M -117.52K -53.56K
Operating Cash Flow -10.92M -12.13M -19.37M -3.87M -3.32M -3.92M -497.36K
Capital Expenditures 3.00 n/a n/a n/a -144.40K -30.83K n/a
Acquisitions n/a n/a n/a 3.01M 86.08K n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a 10.28M n/a n/a n/a
Other Investing Acitivies n/a n/a n/a 1.20M -649.83K -60.00K -115.92M
Investing Cash Flow n/a n/a n/a 14.49M -708.15K -90.83K -115.92M
Debt Repayment -288.07K -530.14K 800.85K 319.43K 2.69M n/a n/a
Common Stock Repurchased n/a -1.01M n/a -9.01M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 196.47K 11.40M -2.06M -119.36K 1.26M 4.77M 116.78M
Financial Cash Flow 5.91M 10.87M 25.41M -8.73M 3.94M 4.77M 116.78M
Net Cash Flow -4.99M -1.25M 6.12M 2.03M -483.82K -157.51K 361.14K
Free Cash Flow -10.92M -12.13M -19.37M -3.87M -3.46M -3.95M -497.36K